Risperidone Long-Acting Injectable (Lai) Suspension Suppliers & Bulk Manufacturers
Available Forms: Long-acting injectable (LAI) suspension
Available Strengths: 25 mg, 37.5 mg, 50 mg per dose
Reference Brands: Risperdal®(US & EU); EU: Risperidon-ratiopharm®, Rispolept®, Rispen®
Category: Antipsychotropic Drugs
Risperidone LAI is an atypical antipsychotic that works by antagonizing dopamine D2 and serotonin 5-HT2A receptors, balancing neurotransmission in the brain. It is indicated for the treatment of schizophrenia and bipolar I disorder in adults, providing consistent plasma levels and improving adherence with biweekly or monthly dosing.
Product Description:
Risperidone Long-Acting Injectable (LAI) suspension is approved by the FDA in the United States and the EMA in the European Union for the treatment of schizophrenia and maintenance therapy in bipolar I disorder. It offers an extended-release formulation designed for intramuscular injection every two weeks or monthly, ensuring steady therapeutic levels and improving medication adherence. Regulatory bodies emphasize its importance in reducing relapse rates and hospitalizations. Prescribers must adhere to initiation protocols, especially when transitioning from oral risperidone. To explore additional forms and strengths of risperidone LAI, visit Pharmatradz.com.
Risperidone Long-Acting Injectable (Lai) Suspension — third party manufacturing & bulk supply
Risperidone Long-Acting Injectable (Lai) Suspension is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Risperidone Long-Acting Injectable (Lai) Suspension listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Risperidone Long-Acting Injectable (Lai)... →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Risperidone injection is used for the treatment of schizophrenia and sometimes bipolar disorder. Long-acting formulations are given to patients who need consistent antipsychotic treatment and may have difficulty taking daily oral medication. It helps control symptoms such as hallucinations, delusions, mood changes, and disorganized thinking.
Risperidone injection is made from the active pharmaceutical ingredient risperidone, an atypical antipsychotic compound that works by affecting dopamine and serotonin receptors in the brain. Long-acting injectable versions use specialized delivery systems that release the medicine slowly over time.
The main trade names include Risperdal Consta, Perseris, Uzedy, and Rykindo, along with several regional brand names depending on the country and manufacturer.
Risperdal Consta is manufactured by Janssen Pharmaceuticals (a Johnson & Johnson company). Perseris is produced by Indivior. Uzedy is developed by Teva Pharmaceuticals in collaboration with Medincell. Rykindo is produced by Luye Pharma Group. In India and other markets, various pharmaceutical manufacturers produce risperidone long-acting injections under licensed or local brands.
The generic name is risperidone.
Major brand names include Risperdal Consta, Perseris, Uzedy, and Rykindo.
Risperidone injections are manufactured in multiple countries depending on the brand, including the United States, European Union countries, China, and India, under approved pharmaceutical manufacturing facilities that comply with regulatory standards such as US FDA, EMA, and other national authorities.
Related Products
Lithium Carbonate
Strength:
150 mg, 300 mg, 600 mg
Form: Tablets
Reference Brands: Lithobid (USA/LATAM), Priadel (EU)
View Details
Phenobarbital Sodium
Strength:
65 mg/mL, 130 mg/mL.
Form: Injection
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers
